Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.35 USD
Change Today +0.0899 / 7.13%
Volume 2.2M
ENZN On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 12:56 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

enzon pharmaceuticals inc (ENZN) Snapshot

Open
$1.27
Previous Close
$1.26
Day High
$1.36
Day Low
$1.25
52 Week High
04/23/15 - $1.88
52 Week Low
06/2/14 - $0.77
Market Cap
59.6M
Average Volume 10 Days
1.8M
EPS TTM
$0.62
Shares Outstanding
44.2M
EX-Date
01/8/15
P/E TM
2.2x
Dividend
--
Dividend Yield
7.41%
Current Stock Chart for ENZON PHARMACEUTICALS INC (ENZN)

enzon pharmaceuticals inc (ENZN) Related Businessweek News

No Related Businessweek News Found

enzon pharmaceuticals inc (ENZN) Details

Enzon Pharmaceuticals, Inc. engages in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for melanoma; Macugen for neovascular (wet) age-related macular degeneration; and CIMZIA for the treatment of rheumatoid arthritis and Crohn’s disease. The company was founded in 1981 and is headquartered in Piscataway, New Jersey.

1 Employees
Last Reported Date: 03/5/15
Founded in 1981

enzon pharmaceuticals inc (ENZN) Top Compensated Officers

Principal Financial Officer, Principal Accoun...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

enzon pharmaceuticals inc (ENZN) Key Developments

Enzon Pharmaceuticals Inc. Announces Special Cash Dividend, Payable on January 28, 2015

On December 4, 2014, the Board of Directors of Enzon Pharmaceuticals Inc. declared a special cash dividend of $0.10 per share of the company's common stock, payable on January 28, 2015 to stockholders of record as of January 12, 2015.

Enzon Pharmaceuticals Inc.(NasdaqCM:ENZN) dropped from Russell 2000 Index

Enzon Pharmaceuticals Inc. will be removed from the Russell 2000 Index.

Enzon Pharmaceuticals Inc.(NasdaqCM:ENZN) dropped from Russell 3000 Index

Enzon Pharmaceuticals Inc. will be removed from the Russell 3000 Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZN:US $1.35 USD +0.0899

ENZN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Depomed Inc $20.80 USD +0.211
Emergent Biosolutions Inc $30.43 USD 0.00
Nektar Therapeutics $11.61 USD +0.08
Onxeo SA €5.52 EUR +0.20
Veloxis Pharmaceuticals A/S kr1.03 DKK +0.02
View Industry Companies
 

Industry Analysis

ENZN

Industry Average

Valuation ENZN Industry Range
Price/Earnings 2.0x
Price/Sales 2.0x
Price/Book 1.5x
Price/Cash Flow 2.0x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZON PHARMACEUTICALS INC, please visit www.enzon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.